Arimidex 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV8C6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,245
Award facts
- Contract value 100% obligated
- $13,244.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,244.63 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on January 30, 2026, with completion scheduled for February 2, 2026. This is a firm fixed-price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle extending through December 31, 2031 that supports pharmaceutical and medical supply delivery to military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company competes on a full and open basis for federal contracts and demonstrates significant capability in fulfilling urgent medical supply needs through its extensive portfolio of brand-name and generic pharmaceutical products across multiple therapeutic domains. This particular delivery order for Arimidex, a hormone therapy medication commonly used in oncology treatment, reflects the company's ongoing role in supplying specialized pharmaceutical products to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV8C6?
SPE2DR26FV8C6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FV8C6 worth?
The government has obligated $13,245 on SPE2DR26FV8C6.
Is contract SPE2DR26FV8C6 an order under another contract?
Yes. SPE2DR26FV8C6 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV8C6 competed?
The extent of competition for SPE2DR26FV8C6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award